US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

685.75

-15.2311-2.17%

Number of Gainers:61

Number of Losers:84

Number of Flat:9

PE:- -

High:703.53

Open:700.98

Low:685.46

Close:700.98

Volume:313.13M

Turnover:10.17B

Market Cap:479.55B

Float Cap:364.16B

Loading ...

Silver Lake’s SLP Fastball Aggregator Disposes of First Advantage Shares Worth $275.19 Million

First Advantage Files Form 3 for Director Sharon Binger

White House to Host Meeting with Crypto Leaders and President Trump

Emmaus Life Sciences Q2 Revenue Soars on Licensing Deal

Senti Biosciences Q2 Net Loss Narrows to $12.75 Million; Revenue Turns to $17,000

UiPath Chief Accounting Officer Hitesh Ramani Reports PATH Share Sale Worth $831,250

Cancer Diagnostics Firm Precipio's Q2 Revenue Rises, Adjusted Ebitda Turns Positive

Zevia Says it Will Review Issues Raised by Kanen Wealth Management

Zevia PBC - to Engage with Shareholders and Board to Review Matters Raised

THOMSON REUTERS

Zevia Statement Regarding Kanen Wealth Management Llc

THOMSON REUTERS

Jana Partners Management, Lp: Change in Holdings are as of June 30, 2026, and Compared with the Previous Quarter Ended as of March 31, 2026

THOMSON REUTERS

Femasys Q2 Net Loss Narrows 2.55% to $4.47 Million; Net Sales Drop 18.9% to $331,827

Robinhood (HOOD) Pushes Deeper into Private Markets with New Y Combinator Fund

Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update

THOMSON REUTERS

Press Release: BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update

Inflammation Drug Developer HCW Biologics' Q2 Net Loss Widens

FTC Release: Statements on the Grant of Early Termination of the FTC's Investigation of IonQ's Proposed Acquisition of SkyWater

Robinhood Expands Private Market Push with Y Combinator-Focused Venture Fund

HCW Biologics Q2 FY26 Net Loss Widens to $5.2 Million; Revenue Rises to $135,568

HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK4539/news?page=28"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":685.7458,"timestamp":1787601599999,"preClose":700.9769,"halted":0,"volume":313126904,"delay":0,"changeRate":-0.021728,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-15.23114,"latestTime":"08-24 16:00:00 EDT","open":700.9787,"high":703.53143,"low":685.4632,"amount":10165204650.256977,"amplitude":0.025776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.436531,"peRate":156.391987,"turnoverRate":0.024191,"increases":61,"decrements":84,"flats":6,"marketCap":479546114433.625,"floatMarketCap":364158638649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":703.53143,"amplitude":0.025776,"preClose":700.9769,"low":685.4632,"pbRate":"5.436531","latestPrice":685.7458,"volume":313126904,"delay":0,"open":700.9787,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":666.772,"twentyDayClose":702.6321,"sixtyDayClose":754.549,"secType":"PLATE","market":"US","turnoverRate":0.024191,"peRate":156.391987,"marketCap":479546114433.625,"floatMarketCap":364158638649,"timestamp":1787601599999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":61,"down":84,"flat":9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:28,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659129726","title":"Silver Lake’s SLP Fastball Aggregator Disposes of First Advantage Shares Worth $275.19 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129726","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129726?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:36","pubTimestamp":1786739794,"startTime":"0","endTime":"0","summary":"Silver Lake’s SLP Fastball Aggregator disposes of First Advantage shares worth $275.19 millionSilver Lake’s SLP Fastball Aggregator reported selling 12.5 million First Advantage common shares on Aug. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL6H8cf7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Silver Lake’s SLP Fastball Aggregator Disposes of First Advantage Shares Worth $275.19 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FA","BK4539","BK4130","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659724129","title":"First Advantage Files Form 3 for Director Sharon Binger","url":"https://stock-news.laohu8.com/highlight/detail?id=2659724129","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659724129?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:36","pubTimestamp":1786739775,"startTime":"0","endTime":"0","summary":"First Advantage files Form 3 for director Sharon BingerFirst Advantage director Sharon Binger filed an initial Form 3 beneficial ownership statement dated Aug. 6, 2026.Disclaimer:This news brief was c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL8vYtBq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4130","BK4539","FA","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150640740","title":"White House to Host Meeting with Crypto Leaders and President Trump","url":"https://stock-news.laohu8.com/highlight/detail?id=1150640740","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150640740?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:22","pubTimestamp":1786738933,"startTime":"0","endTime":"0","summary":"Key executives from Coinbase, Andreessen Horowitz (a16z), Kalshi, Ripple, and Chainlink are anticipated to attend a White House meeting on Wednesday, as reported by Semafor on X.The meeting is...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","FDIG","XRP.USD.CC","BK4516","XXRP","CONI","XRPT","COIA","XRPR","UXRP","LU1861217088.USD","BK4077","BITQ","FIAT","DJT","CONX","COIG","ICOI","XRPI","LU1861558580.USD","LU1861559042.SGD","XRPK","COIO","BLCK","DJTU","IBLC","COYY","BK4595","TRUMP.USD.CC","BK4535","CONL","COII","CONY","BK4585","LU1861220207.SGD","FINX","LU2360107671.USD","BK4112","COIN","BK4554","BKCH","CRPT","BK4551","BK4600","COIW","BK4596","BK4539","BK4547"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129647","title":"Emmaus Life Sciences Q2 Revenue Soars on Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129647","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129647?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:20","pubTimestamp":1786738826,"startTime":"0","endTime":"0","summary":"Emmaus Life Sciences Q2 revenue soars on licensing dealOverviewUS biopharmaceutical firm's Q2 revenue rose 124% yr/yr, driven by NIT license agreementCompany reduced operating expenses following sales","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0W7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EMMA","BK4539","RANI","ETON","BK4139","BK4007","MGTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129597","title":"Senti Biosciences Q2 Net Loss Narrows to $12.75 Million; Revenue Turns to $17,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129597","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129597?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:17","pubTimestamp":1786738635,"startTime":"0","endTime":"0","summary":"Senti Biosciences Q2 net loss narrows to $12.75 million; revenue turns to $17,000Senti Biosciences Holdings posted a Q2 net loss of USD 12.75 million, narrowing from USD 14.73 million a year earlier.R","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL5ZD2MQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SNTI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129328","title":"UiPath Chief Accounting Officer Hitesh Ramani Reports PATH Share Sale Worth $831,250","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129328","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129328?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:15","pubTimestamp":1786738509,"startTime":"0","endTime":"0","summary":"UiPath Chief Accounting Officer Hitesh Ramani reports PATH share sale worth $831,250UiPath Chief Accounting Officer Hitesh Ramani sold 50,000 Class A common shares on Aug. 13-14, SEC filing shows.Sale","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL4xWrm5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"UiPath Chief Accounting Officer Hitesh Ramani Reports PATH Share Sale Worth $831,250","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4097","BK4561","BK4585","PATH","BK4539","BK4604","BK4547","BK4551","BK4505","LU1861559042.SGD","PATX","BK4543","BK4588","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659912609","title":"Cancer Diagnostics Firm Precipio's Q2 Revenue Rises, Adjusted Ebitda Turns Positive","url":"https://stock-news.laohu8.com/highlight/detail?id=2659912609","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659912609?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:10","pubTimestamp":1786738233,"startTime":"0","endTime":"0","summary":"Cancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positiveOverviewUS specialty cancer diagnostics firm's Q2 revenue rose 22% yr/yr to $7.0 mlnAdjusted EBITDA improved to $0.4 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0VE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4148","PRPO","BK4082","AKTS","BK4196","BK4139","CODX","BK4539","RNXT","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659312677","title":"Zevia Says it Will Review Issues Raised by Kanen Wealth Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2659312677","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659312677?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:09","pubTimestamp":1786738153,"startTime":"0","endTime":"0","summary":"Zevia says it will review issues raised by Kanen Wealth ManagementZevia responded to Kanen Wealth Management’s press release, signaling willingness to engage with shareholders on strategic priorities.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL3DyJ5L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZVIA","BK4539","BK4177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126729","title":"Zevia PBC - to Engage with Shareholders and Board to Review Matters Raised","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126729?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:09","pubTimestamp":1786738149,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nFWN44B1RZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4177","ZVIA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126728","title":"Zevia Statement Regarding Kanen Wealth Management Llc","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126728","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126728?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:09","pubTimestamp":1786738149,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nFWN44B1RZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ZVIA","BK4539","BK4177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129474","title":"Jana Partners Management, Lp: Change in Holdings are as of June 30, 2026, and Compared with the Previous Quarter Ended as of March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129474","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129474?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:07","pubTimestamp":1786738056,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nFWN44B1UT:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4106","LU0354030438.USD","IE0031619046.USD","FISV","BK4585","LU1046421795.USD","LU2125909759.SGD","FINX","LU0980610538.SGD","LU0208291251.USD","LU0130103400.USD","BK4187","BK4212","LU1201861249.SGD","IE00B66KJ199.SGD","BK4227","LU1815336091.USD","MRCY","LU1878469433.USD","BK4588","LU0648000940.SGD","LU0757428866.USD","IE00B7SZL793.SGD","ALKT","LU0648001328.SGD","LU0130102774.USD","LU1823568750.SGD","BK4539","LW","LU2125909916.SGD","LU1861220207.SGD","LU0070302665.USD","BK4023","LU0354030511.USD","LU1923622291.USD","LU1201861165.SGD","LU1861217088.USD","LU0320765489.SGD","IE00B19Z4B17.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126762","title":"Femasys Q2 Net Loss Narrows 2.55% to $4.47 Million; Net Sales Drop 18.9% to $331,827","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126762","media":"Reuters","labels":["executive","shareholding","corporation","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126762?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:06","pubTimestamp":1786738006,"startTime":"0","endTime":"0","summary":"Femasys Q2 net loss narrows 2.55% to $4.47 million; net sales drop 18.9% to $331,827Femasys posted a Q2 net loss of USD 4.47 million, or USD 1.33 per share, versus a year-earlier net loss of USD 4.59 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL4GywSL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,shareholding,corporation,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","FEMY","BK4588","BK4584","IE00BN0W2T93.GBP","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4082","SG9999014013.SGD","SG9999014005.SGD","BK4112","BK4585","LU0314104364.USD","IE00BN0W2V16.EUR","BK4539","LU2095319765.USD","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","BCDF","SG9999014021.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659129943","title":"Robinhood (HOOD) Pushes Deeper into Private Markets with New Y Combinator Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2659129943","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659129943?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:06","pubTimestamp":1786737984,"startTime":"0","endTime":"0","summary":"Investor demand is growing for access to pre-IPO companies.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/robinhood-hood-pushes-deeper-into-private-markets-with-new-y-combinator-fund?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/robinhood-hood-pushes-deeper-into-private-markets-with-new-y-combinator-fund?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4127","BK4547","LU1861559042.SGD","LU1861558580.USD","BK4539","CRPT","IAI","BLCK","HOYY","HOOX","HOOW","HOII","HOOD","HOOZ","HOOI","HOOG","ROBN","BPAY","FINX","HOOY","HODU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126229","title":"Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126229?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:05","pubTimestamp":1786737901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA4QFSV6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","FEMY","BK4082","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659012647","title":"Press Release: BrainStorm Cell Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659012647","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659012647?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:00","pubTimestamp":1786737600,"startTime":"0","endTime":"0","summary":"NEW YORK, Aug. 14, 2026 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the second quarter ended June 30, 2026, and provided a corporate update.\"We continue to advance and complete the preparations necessary to initiate the Phase 3b ENDURANCE study of NurOwn in ALS, supported by an FDA-agreed protocol under a Special Protocol Assessment,\" said Chaim Lebovits, President and Chief Executive Officer of BrainStorm. \"The recent appointment of Peter Pitts as Executive Chairman represents an important enhancement to our leadership. Peter is joining the Company in an active executive capacity and will help lead the regulatory, operational, partnership and capital-markets initiatives surrounding the NurOwn program. His experience as a former senior FDA official brings an additional level of regulatory insight and strategic perspective as we prepare to enter this next pha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","R","BK4022","BK4539","BK4139","BK4007","LENZ","BCLI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659312657","title":"Inflammation Drug Developer HCW Biologics' Q2 Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2659312657","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659312657?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:29","pubTimestamp":1786735753,"startTime":"0","endTime":"0","summary":"Inflammation drug developer HCW Biologics' Q2 net loss widensOverviewUS biopharma firm's Q2 revenue rose yr/yr, driven by licensing agreement completionCompany posted higher Q2 net loss compared to pr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL1N44B0TM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MGTX","BK4539","RANI","BK4007","BK4139","VTGN","HCWB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126582","title":"FTC Release: Statements on the Grant of Early Termination of the FTC's Investigation of IonQ's Proposed Acquisition of SkyWater","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126582","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126582?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:24","pubTimestamp":1786735440,"startTime":"0","endTime":"0","summary":"The Federal Trade Commission granted early termination of its review of quantum computing developer IonQ Inc.'s proposed acquisition of SkyWater Technologies Inc., a quantum chip fabrication company.V","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IONX","BK4170","BK4591","BK4602","SKYT","IONZ","IONL","IOYY","IONQ","BK4141","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659263241","title":"Robinhood Expands Private Market Push with Y Combinator-Focused Venture Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2659263241","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659263241?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:19","pubTimestamp":1786735140,"startTime":"0","endTime":"0","summary":"Robinhood Markets deepened its push into private markets with the launch on Thursday of its second venture fund, Robinhood Ventures Fund II, which provides investors with access to private companies.S","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAI","BLCK","HOOI","BK4547","HOOD","HOII","HOOX","HOYY","FINX","CRPT","ROBN","BPAY","HOOZ","HOOW","HOOY","LU1861558580.USD","HODU","LU1861559042.SGD","HOOG","BK4539","BK4127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659319126","title":"HCW Biologics Q2 FY26 Net Loss Widens to $5.2 Million; Revenue Rises to $135,568","url":"https://stock-news.laohu8.com/highlight/detail?id=2659319126","media":"Reuters","labels":["shareholding","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659319126?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:15","pubTimestamp":1786734920,"startTime":"0","endTime":"0","summary":"HCW Biologics Q2 FY26 net loss widens to $5.2 million; revenue rises to $135,568HCW Biologics posted Q2 net loss of USD 5.2 million, widening from USD 1.9 million a year earlier.Revenue climbed to USD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL1vn6zJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","LU2210149790.SGD","LU2210150020.SGD","LU2095319765.USD","IE00BGHQF748.EUR","HCWB","SG9999014021.USD","BK4588","NDAQ","BK4585","IE00BKPKM429.USD","IE00B64PRP62.GBP","LU0314104364.USD","BK4539","SG9999014039.USD","BCDF","BK4139","SG9999014013.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659126316","title":"HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659126316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659126316?lang=en_us&edition=fundamental","pubTime":"2026-08-15 03:15","pubTimestamp":1786734900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA3S5H4S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","HCWB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":54,"pageCount":28,"totalSize":1077,"code":"91000000","status":"200"}]}}